In Vitro Antiviral Activity of Lutein against Hepatitis B Virus

被引:37
作者
Pang, Ran [1 ]
Tao, Jun-Yan [2 ]
Zhang, Shu-Ling [1 ]
Zhao, Lei [1 ]
Yue, Xin [2 ]
Wang, Yue-Feng [1 ]
Ye, Pian [1 ]
Dong, Ji-Hua [3 ]
Zhu, Ying [2 ]
Wu, Jian-Guo [2 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Hepatol & Infect Dis, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China
[2] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China
[3] Huazhong Univ Sci & Technol, Cent Lab, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China
关键词
hepatitis B virus; lutein; HBsAg; HBeAg; HBV DNA; HBV promoter; RISK; CAROTENOIDS; PROTEIN; CELLS;
D O I
10.1002/ptr.3155
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Despite the availability of an effective vaccine, the hepatitis B virus (HBV) infection and its treatment remains one of the foremost public health problems in the world. The present study was performed in order to investigate the anti-HBV activity of lutein in vitro. The antiviral activity of lutein was examined by detecting the levels of HBsAg, HBeAg and extracellular HBV DNA in stable HBV-producing human hepatoblastoma HepG2 2.2.15 cells. It was found that lutein effectively suppressed the secretion of HBsAg from HepG2 2.2.15 cells in a dose-dependent manner, and it also suppressed the amount of extracellular HBV DNA. A luciferase reporter gene assay was used to determine the effects of lutein on the activities of HBV promoters. The results showed that lutein inhibited the activity of HBV full-length promoter (Fp). These data indicate that lutein possesses an anti-HBV activity and exerts its antivirus effects via inhibition of HBV transcription. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1627 / 1630
页数:4
相关论文
共 17 条
[1]   Exploiting the RNA interference pathway to counter hepatitis B virus replication [J].
Arbuthnot, P ;
Carmona, S ;
Ely, A .
LIVER INTERNATIONAL, 2005, 25 (01) :9-15
[2]   Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[3]   Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study [J].
Chen, Gang ;
Lin, Wenyao ;
Shen, Fumin ;
Iloeje, Uchenna H. ;
London, W. Thomas ;
Evans, Alison A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08) :1797-1803
[4]   Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein α synergistically activates the hepatitis B viral enhancer II pregenomic promoter [J].
Choi, BH ;
Park, GT ;
Rho, HM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :2858-2865
[5]   Predicting cirrhosis risk based on the level of circulating hepatitis B viral load [J].
Iloeje, UH ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Chen, CJ .
GASTROENTEROLOGY, 2006, 130 (03) :678-686
[6]   Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture [J].
Kozuki, Y ;
Miura, Y ;
Yagasaki, K .
CANCER LETTERS, 2000, 151 (01) :111-115
[7]   Therapy of chronic hepatitis B: current challenges and opportunities [J].
Liaw, YF .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (06) :393-399
[8]   The Natural History of Chronic Hepatitis B Virus Infection [J].
McMahon, Brian J. .
HEPATOLOGY, 2009, 49 (05) :S45-S55
[9]   Regulatory elements of hepatitis B virus transcription [J].
Moolla, N ;
Kew, M ;
Arbuthnot, P .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (05) :323-331
[10]   Inhibitory effects of natural carotenoids, alpha-carotene, beta-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats [J].
Narisawa, T ;
Fukaura, Y ;
Hasebe, M ;
Ito, M ;
Aizawa, R ;
Murakoshi, M ;
Uemura, S ;
Khachik, F ;
Nishino, H .
CANCER LETTERS, 1996, 107 (01) :137-142